The landmark FLOW study shows the benefits extend to kidney, cardiovascular, and mortality outcomes in high-risk patients with type 2 diabetes and CKD.
Chronic Kidney Disease Incidence Differs by Race in People With Diabetes clinicaladvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaladvisor.com Daily Mail and Mail on Sunday newspapers.
Investigators report promising results from a phase 2 trial of an investigational aldosterone synthase inhibitor. BI 690517, a novel investigational aldosterone synthase inhibitor, may improve clinicians’ ability to slow progression of chronic kidney disease.
Research presented at the American Society of Nephrology meeting medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.